Matthew L. Wein - 01 Apr 2024 Form 4 Insider Report for Metagenomi, Inc. (MGX)

Role
Title: Vice President of Corporate Legal and Compliance, and Corporate Secretary
Signature
/s/ Matthew L. Wein
Issuer symbol
MGX
Transactions as of
01 Apr 2024
Net transactions value
$0
Form type
4
Filing time
03 Apr 2024, 20:57:27 UTC
Previous filing
08 Feb 2024
Next filing
07 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGX Common Stock Award $0 +10,397 $0.000000 10,397 01 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGX Stock Option (Right to Buy) Award $0 +43,717 $0.000000 43,717 01 Apr 2024 Common Stock 43,717 $10.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on March 5, 2025, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
F2 25% of the shares subject to this option shall vest and become exercisable on February 1, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Remarks:

Title: Vice President of Corporate Legal and Compliance, and Corporate Secretary